Reimbursement of Travel and Subsistence Expenses Toward Living Organ Donation Proposed Eligibility Guidelines, 17564-17566 [E7-6598]
Download as PDF
17564
Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices
In an effort to develop drug products
that are more convenient to use and to
address potential issues of patient
compliance for certain product
indications and patient populations,
pharmaceutical manufacturers have
developed products that can be ingested
simply by placing them on the tongue.
The products are designed to
disintegrate or dissolve rapidly on
contact with saliva, thus eliminating the
need for chewing the tablet, swallowing
an intact tablet, or taking the tablet with
water. This mode of administration was
initially expected to be beneficial to
pediatric and geriatric patients, to
people with conditions related to
impaired swallowing, and for treatment
of patients when compliance may be
difficult (e.g., for psychiatric disorders).
As firms started developing additional
products using different technology and
formulations, many of these later
products exhibited wide variation in
product characteristics from the initial
products. Because this shift in product
characteristics can affect a product’s
suitability for particular uses, the
agency developed this guidance for
industry.
This draft guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the agency’s current thinking
on orally disintegrating tablets. It does
not create or confer any rights for or on
any person and does not operate to bind
FDA or the public. An alternative
approach may be used if such approach
satisfies the requirements of the
applicable statutes and regulations.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
sroberts on PROD1PC70 with NOTICES
III. Electronic Access
Persons with access to the Internet
may obtain the document at either
https://www.fda.gov/cder/guidance/
index.htm or https://www.fda.gov/
ohrms/dockets/default.htm.
VerDate Aug<31>2005
18:21 Apr 06, 2007
Jkt 211001
Dated: March 30, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–6509 Filed 4–6–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Council on Graduate Medical
Education; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Council on Graduate Medical
Education (COGME).
Dates and Times: April 30, 2007, 8:30
a.m.– 5 p.m.; and May 1, 2007, 8:30 a.m.–
2:30 p.m.
Place: Hilton Washington, DC/Rockville
Executive Meeting Center, 1750 Rockville
Pike, Rockville, Maryland 20852–1699.
Status: The meeting will be open to the
public.
Agenda: The agenda for April 30 in the
morning will include: Welcome and opening
comments from the Chair and Executive
Secretary of COGME and senior management
staff of the Health Resources and Services
Administration.
On April 30, following the welcoming
remarks from the COGME Chair, the
Executive Secretary of COGME, and Agency
senior management, there will be a review
and discussion of the draft paper ‘‘Enhancing
GME Flexibility,’’ by Barbara Chang, M.D.,
and other writing group members. After
lunch there will be a review and discussion
of the draft paper ‘‘New Paradigms for
Physician Training for Improving Access to
Healthcare’’ by Earl Reisdorff, M.D. and other
writing group members. At 3 p.m. there will
be a breakout of Council members into the
two draft writing groups for further report
revisions.
On May 1 there will be reports to the
Council and further discussion on writing
group activities and reports. The Council will
conclude with a discussion of the timeframe
and next steps for producing the Reports.
Agenda items are subject to change as
priorities dictate.
FOR FURTHER INFORMATION CONTACT:
Jerald M. Katzoff, Executive Secretary,
COGME, Division of Medicine and
Dentistry, Bureau of Health Professions,
Parklawn Building, Room 9A–27, 5600
Fishers Lane, Rockville, Maryland
20857, Telephone (301) 443–6785.
Dated: April 2, 2007.
Caroline Lewis,
Acting Associate Administrator for
Administration and Financial Management.
[FR Doc. E7–6597 Filed 4–6–07; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Reimbursement of Travel and
Subsistence Expenses Toward Living
Organ Donation Proposed Eligibility
Guidelines
Health Resources and Services
Administration (HRSA), HHS.
ACTION: Request for Public Comment.
AGENCY:
SUMMARY: HRSA is soliciting comments
on the proposed eligibility criteria for
the Reimbursement of Travel and
Subsistence Expenses toward Living
Organ Donations Program. Eligibility
criteria were proposed by the program
grantee, the Regents of the University of
Michigan, to HRSA. HRSA has
determined that the proposed eligibility
criteria constitute a proper
interpretation of the authorizing
statute’s requirements, including
determinations as to which individuals
would otherwise be unable to meet the
eligible expenses authorized under this
Program. HRSA is soliciting public
comment on the criteria outlined in this
notice. HRSA will consider the
comments in light of the authorizing
statute and seek feedback from the
Regents of the University of Michigan
concerning the comments. HRSA will
then approve final criteria. The final
program eligibility criteria will be
posted on the Reimbursement of Travel
and Subsistence Expenses for Living
Organ Donation Web site, https://
www.livingdonorassistance.org.
Written comments must be
submitted to the office in the address
section below by mail or e-mail on or
before May 24, 2007.
ADDRESSES: Please send all written
comments to James F. Burdick, M.D.,
Director, Division of Transplantation,
Healthcare Systems Bureau, Health
Resources and Services Administration,
Room 12C–06, Parklawn Building, 5600
Fishers Lane, Rockville, Maryland
20857; telephone (301) 443–7577; fax
(301) 594–6095; or e-mail:
jburdick@hrsa.gov.
DATES:
FOR FURTHER INFORMATION CONTACT:
James F. Burdick, M.D., Director,
Division of Transplantation, Healthcare
Systems Bureau, Health Resources and
Services Administration, Parklawn
Building, Room 12C–06, 5600 Fishers
Lane, Rockville, Maryland 20857;
telephone (301) 443–7577; fax (301)
594–6095; or e-mail: jburdick@hrsa.gov.
SUPPLEMENTARY INFORMATION: Congress
has provided specific authority under
E:\FR\FM\09APN1.SGM
09APN1
17565
Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices
section 377 of the Public Health Service
(PHS) Act, as amended, 42 U.S.C. 274f,
for providing reimbursement of travel
and subsistence expenses for certain
living organ donors, with preference for
those for whom paying such expenses
would create a financial hardship. On
September 25, 2006, HRSA awarded a 4year, $8,000,000, Cooperative
Agreement to the Regents of the
University of Michigan to establish this
program.
The authorizing statute stipulates that
the Secretary, in carrying out this
program, shall give preference to those
individuals that the Secretary
determines are more likely to be
otherwise unable to meet such
expenses. HRSA asked the grantee to
propose eligibility criteria to HRSA to
satisfy this requirement.
The two main issues raised in
developing the program eligibility
criteria are:
(1) Which criteria should be used to
identify potential living organ donors
who may be unable to pay for travel and
subsistence expenses associated with
living organ donation? This issue is
important because such donors are to
receive priority under this program; and
(2) Which criteria should be
established to assess the potential organ
recipient’s ability to pay the living
donor’s travel and subsistence
expenses? This determination is
significant because the authorizing
statute provides that payments are not
to be made if a donor’s eligible expenses
have been, or reasonably can be
expected to be, paid by the organ
recipient.
This program is intended for
individuals with end stage organ failure
for whom a transplant from a suitable
living donor is a viable therapy. The
purpose of this solicitation of comments
is to obtain feedback from the public on
the proposed eligibility criteria. These
comments are important to assure that
the needs and concerns of the general
public, including its views as to the
optimal means of carrying out the
program’s objectives, are addressed.
After considering the comments, HRSA
will approve final criteria, which will be
posted on the Reimbursement of Travel
and Subsistence Expenses for Living
Organ Donation Web site, https://
www.livingdonorassistance.org.
Proposed Eligibility Guidelines
The program’s authorizing legislation
explicitly states that funds ‘‘will not be
expended to pay the qualifying
expenses of a donating individual to the
extent that payment has been made, or
can reasonably be expected to be made,
with respect to such expenses:
(1) Under any State compensation
program, under an insurance policy, or
under any Federal or State health
benefits program;
(2) By an entity that provides health
services on a prepaid basis; or
(3) By the recipient of the organ.’’
In implementing this authority, the
proposed threshold of income eligibility
for the recipient of the organ is 200% of
the HHS Poverty Guidelines (described
below). At any income above this
measure, it can reasonably be expected
that the recipient of the organ could pay
for the donor’s qualifying expenses.
However, the transplant social worker
or appropriate transplant center
personnel involved in the potential
transplant recipient’s evaluation process
can provide a written justification that
notwithstanding the potential transplant
recipient’s income level, significant
financial hardship is likely to be
encountered by the potential transplant
recipient of the organ for the payment
of the donor’s qualifying expenses in the
course of the donation process. This
justification will be given consideration
by the program’s Review Committee.
All live organ donors are eligible for
reimbursement of qualifying expenses
provided all the criteria for donor
reimbursement are fulfilled. However,
subject to availability of funds,
preference will be given to donors who
are more likely to be otherwise unable
to meet the qualifying expenses, in the
following proposed order of priority:
Preference Category 1: Donor income
and recipient anticipated income each is
≤200% of the HHS Poverty Guidelines
in their respective States of primary
residence.
Preference Category 2: Donor income
is ≤200% of the HHS Poverty Guidelines
in the State of primary residence.
Preference Category 3: Recipient
anticipated income is ≤200% of the
HHS Poverty Guidelines in the State of
primary residence.
Preference Category 4: Donors who
can demonstrate that notwithstanding
their income level, significant financial
hardship is likely to be encountered for
qualifying non-medical expenses in the
course of the donation process.
Preference Category 5: Any live organ
donor, notwithstanding income level or
financial hardship, who meets the
criteria for donor reimbursement.
Recipient anticipated income is the
total income from all sources that the
recipient is expected to receive in the
year in which live donor organ
transplantation will occur for the
patient with previous existing organ
failure or the subsequent calendar year
after the year of onset of end stage organ
failure for a new patient with end stage
organ failure. The HHS Poverty
Guidelines are updated periodically and
the guidelines in effect at the time of
application will be applied. As an
illustration, the HHS Poverty Guidelines
for 2006 (71 Fed. Reg. 3848) are shown
in the table below.
2006 HHS POVERTY GUIDELINES
48 Contiguous
states and DC
Persons in family or household
sroberts on PROD1PC70 with NOTICES
1 ...................................................................................................................................................
2 ...................................................................................................................................................
3 ...................................................................................................................................................
4 ...................................................................................................................................................
5 ...................................................................................................................................................
6 ...................................................................................................................................................
7 ...................................................................................................................................................
8 ...................................................................................................................................................
For each additional person, add ..................................................................................................
$9,800
13,200
16,600
20,000
23,400
26,800
30,200
33,600
3,400
Source: 71 FR 3848 (Jan. 24, 2006).
VerDate Aug<31>2005
18:21 Apr 06, 2007
Jkt 211001
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
E:\FR\FM\09APN1.SGM
09APN1
Alaska
$12,250
16,500
20,750
25,000
29,250
33,500
37,750
42,000
4,250
Hawaii
$11,270
15,180
19,090
23,000
26,910
30,820
34,730
38,640
3,910
17566
Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices
Proposed Qualifying Expenses
sroberts on PROD1PC70 with NOTICES
Proposed Criteria for Donor
Reimbursement
In addition to the eligibility and
priority guidelines discussed above, the
following criteria for donor
reimbursement are proposed:
1. Any individual who in good faith
incurs qualifying expenses toward the
intended donation of an organ but with
respect to whom, for such reasons as the
Secretary determines to be appropriate,
no donation of the organ occurs (see
special provision). This criteria is
specifically discussed in the authorizing
statute.
2. Donor and recipient of the organ
are either U.S. citizens or lawfully
admitted residents of the U.S.
3. Donor and recipient have primary
residence in the U.S. or its territories.
4. Travel is originating from the
donor’s primary residence.
5. Donor meets the criteria for
informed consent for the planned
procedure according to applicable State
and Federal laws.
6. Donor and recipient are not
participating in a paired exchange
program or a living donor/deceased
donor exchange for the particular
donation procedure for which
reimbursement is being sought unless
the legality of such practices is clarified
by the Federal Government.
7. Donor and recipient attest to full
compliance with section 301 of the
National Organ Transplant Act (NOTA),
as amended (42 U.S.C. 274e) which
stipulates in part that ‘‘ * * * [i]t shall
be unlawful for any person to
knowingly acquire, receive, or otherwise
transfer any human organ for valuable
consideration for use in human
transplantation if the transfer affects
interstate commerce.’’
8. The transplant center where the
donation procedure occurs attests to its
status of good standing with the Organ
Procurement and Transplantation
Network (i.e., it is not a Member Not in
Good Standing) and assurance that the
program follows best practices for the
health and safety of living donors such
as the recommendations provided in the
Consensus Statement of the Ethics
Committee of the Vancouver Forum on
living organ donation (Source: Pruett
TL, Tibell A, Alabdulkareem A,
Bhandari M, Cronin DC, Dew MA, DibKuri A, Gutmann T, Matas A, McMurdo
L, Rahmel A, Rizvi SA, Wright L,
Delmonico FL. The ethics statement of
the Vancouver Forum on the live lung,
liver, pancreas, and intestine donor.
Transplantation 81(10):1386–1387;
(2006).
The public is invited to submit
comments on these criteria.
VerDate Aug<31>2005
18:21 Apr 06, 2007
Jkt 211001
For the purpose of the Reimbursement
of Travel and Subsistence Expenses
toward Living Organ Donation Program,
qualifying expenses presently include
only travel, lodging, and meals and
incidental expenses incurred by the
donor and/or accompanying person(s)
as part of:
(1) Donor evaluation clinic visit or
hospitalization;
(2) Hospitalization for the living
donor surgical procedure; and/or
(3) Medical or surgical follow-up
clinic visit or hospitalization within 90
days after the living donation
procedure.
The Program will pay for up to five
trips per donation or intended donation.
Three of these trips may be for the
potential living donor and up to two
trips may be for any accompanying
person(s). The total Federal
reimbursement for qualified expenses
during the donation process for the
donor and accompanying individuals
shall not exceed $6,000.
The public is invited to submit
comments on these criteria.
Special Provisions
The authorizing statute provides that
the Secretary may consider as an
eligible donating individual a person
who in good faith incurs qualifying
expenses toward the intended donation
of an organ but with respect to whom,
for reasons the Secretary determines to
be appropriate, no donation of the organ
occurs. Many factors may prevent the
intended and willing donor from
proceeding with the donation. Such
circumstances include present health
status of the intended donor or recipient
that would prevent the transplant or
donation from proceeding, perceived
long-term risks to the intended donor,
circumstances such as acts of God (e.g.,
major storms or hurricanes), or other
unforeseen events outside of the
intended donor’s control. In such cases,
the intended donor and accompanying
persons may receive reimbursement for
the qualified expenses incurred. In the
case that a potential donor no longer
wishes to donate, he or she may receive
reimbursement for qualified expenses
incurred. However, payments received
for expenses that were not incurred by
the intended donor and accompanying
persons must be refunded. Otherwise,
such payment will be treated as income
to the intended donor, and in
accordance with Internal Revenue
Service (IRS) regulations, the Regents of
the University of Michigan shall notify
the IRS (Form 1099) that a payment has
been made to the intended donor in the
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
amount equivalent to the unexpended
payment.
Dated: March 30, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7–6598 Filed 4–6–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Establishment; Pursuant to
the Federal Advisory Committee Act,
as Amended (5 U.S.C. Appendix 2), the
Director, National Institutes of Health
(NIH), Announces the Establishment of
the Council of Councils (Council)
The Council shall provide advice and
recommendations to the Director, NIH,
or other appropriate delegated officials
on matters related to the policies and
activities of the Division of Program
Coordination, Planning, and Strategic
Initiatives including making
recommendations with respect to the
conduct and support of research that
represents important areas of emerging
scientific opportunities, rising public
health challenges, or knowledge gaps
that deserve special emphasis and
would benefit from conducting or
supporting additional research that
involves collaboration between two or
more national research institutes or
national centers, or would otherwise
benefit from strategic coordination and
planning.
Duration of this committee is two
years from the date the Charter is filed.
Dated: March 29, 2007.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 07–1730 Filed 4–6–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
E:\FR\FM\09APN1.SGM
09APN1
Agencies
[Federal Register Volume 72, Number 67 (Monday, April 9, 2007)]
[Notices]
[Pages 17564-17566]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6598]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Reimbursement of Travel and Subsistence Expenses Toward Living
Organ Donation Proposed Eligibility Guidelines
AGENCY: Health Resources and Services Administration (HRSA), HHS.
ACTION: Request for Public Comment.
-----------------------------------------------------------------------
SUMMARY: HRSA is soliciting comments on the proposed eligibility
criteria for the Reimbursement of Travel and Subsistence Expenses
toward Living Organ Donations Program. Eligibility criteria were
proposed by the program grantee, the Regents of the University of
Michigan, to HRSA. HRSA has determined that the proposed eligibility
criteria constitute a proper interpretation of the authorizing
statute's requirements, including determinations as to which
individuals would otherwise be unable to meet the eligible expenses
authorized under this Program. HRSA is soliciting public comment on the
criteria outlined in this notice. HRSA will consider the comments in
light of the authorizing statute and seek feedback from the Regents of
the University of Michigan concerning the comments. HRSA will then
approve final criteria. The final program eligibility criteria will be
posted on the Reimbursement of Travel and Subsistence Expenses for
Living Organ Donation Web site, https://www.livingdonorassistance.org.
DATES: Written comments must be submitted to the office in the address
section below by mail or e-mail on or before May 24, 2007.
ADDRESSES: Please send all written comments to James F. Burdick, M.D.,
Director, Division of Transplantation, Healthcare Systems Bureau,
Health Resources and Services Administration, Room 12C-06, Parklawn
Building, 5600 Fishers Lane, Rockville, Maryland 20857; telephone (301)
443-7577; fax (301) 594-6095; or e-mail: jburdick@hrsa.gov.
FOR FURTHER INFORMATION CONTACT: James F. Burdick, M.D., Director,
Division of Transplantation, Healthcare Systems Bureau, Health
Resources and Services Administration, Parklawn Building, Room 12C-06,
5600 Fishers Lane, Rockville, Maryland 20857; telephone (301) 443-7577;
fax (301) 594-6095; or e-mail: jburdick@hrsa.gov.
SUPPLEMENTARY INFORMATION: Congress has provided specific authority
under
[[Page 17565]]
section 377 of the Public Health Service (PHS) Act, as amended, 42
U.S.C. 274f, for providing reimbursement of travel and subsistence
expenses for certain living organ donors, with preference for those for
whom paying such expenses would create a financial hardship. On
September 25, 2006, HRSA awarded a 4-year, $8,000,000, Cooperative
Agreement to the Regents of the University of Michigan to establish
this program.
The authorizing statute stipulates that the Secretary, in carrying
out this program, shall give preference to those individuals that the
Secretary determines are more likely to be otherwise unable to meet
such expenses. HRSA asked the grantee to propose eligibility criteria
to HRSA to satisfy this requirement.
The two main issues raised in developing the program eligibility
criteria are:
(1) Which criteria should be used to identify potential living
organ donors who may be unable to pay for travel and subsistence
expenses associated with living organ donation? This issue is important
because such donors are to receive priority under this program; and
(2) Which criteria should be established to assess the potential
organ recipient's ability to pay the living donor's travel and
subsistence expenses? This determination is significant because the
authorizing statute provides that payments are not to be made if a
donor's eligible expenses have been, or reasonably can be expected to
be, paid by the organ recipient.
This program is intended for individuals with end stage organ
failure for whom a transplant from a suitable living donor is a viable
therapy. The purpose of this solicitation of comments is to obtain
feedback from the public on the proposed eligibility criteria. These
comments are important to assure that the needs and concerns of the
general public, including its views as to the optimal means of carrying
out the program's objectives, are addressed. After considering the
comments, HRSA will approve final criteria, which will be posted on the
Reimbursement of Travel and Subsistence Expenses for Living Organ
Donation Web site, https://www.livingdonorassistance.org.
Proposed Eligibility Guidelines
The program's authorizing legislation explicitly states that funds
``will not be expended to pay the qualifying expenses of a donating
individual to the extent that payment has been made, or can reasonably
be expected to be made, with respect to such expenses:
(1) Under any State compensation program, under an insurance
policy, or under any Federal or State health benefits program;
(2) By an entity that provides health services on a prepaid basis;
or
(3) By the recipient of the organ.''
In implementing this authority, the proposed threshold of income
eligibility for the recipient of the organ is 200% of the HHS Poverty
Guidelines (described below). At any income above this measure, it can
reasonably be expected that the recipient of the organ could pay for
the donor's qualifying expenses. However, the transplant social worker
or appropriate transplant center personnel involved in the potential
transplant recipient's evaluation process can provide a written
justification that notwithstanding the potential transplant recipient's
income level, significant financial hardship is likely to be
encountered by the potential transplant recipient of the organ for the
payment of the donor's qualifying expenses in the course of the
donation process. This justification will be given consideration by the
program's Review Committee.
All live organ donors are eligible for reimbursement of qualifying
expenses provided all the criteria for donor reimbursement are
fulfilled. However, subject to availability of funds, preference will
be given to donors who are more likely to be otherwise unable to meet
the qualifying expenses, in the following proposed order of priority:
Preference Category 1: Donor income and recipient anticipated
income each is <=200% of the HHS Poverty Guidelines in their respective
States of primary residence.
Preference Category 2: Donor income is <=200% of the HHS Poverty
Guidelines in the State of primary residence.
Preference Category 3: Recipient anticipated income is <=200% of
the HHS Poverty Guidelines in the State of primary residence.
Preference Category 4: Donors who can demonstrate that
notwithstanding their income level, significant financial hardship is
likely to be encountered for qualifying non-medical expenses in the
course of the donation process.
Preference Category 5: Any live organ donor, notwithstanding income
level or financial hardship, who meets the criteria for donor
reimbursement.
Recipient anticipated income is the total income from all sources
that the recipient is expected to receive in the year in which live
donor organ transplantation will occur for the patient with previous
existing organ failure or the subsequent calendar year after the year
of onset of end stage organ failure for a new patient with end stage
organ failure. The HHS Poverty Guidelines are updated periodically and
the guidelines in effect at the time of application will be applied. As
an illustration, the HHS Poverty Guidelines for 2006 (71 Fed. Reg.
3848) are shown in the table below.
2006 HHS Poverty Guidelines
----------------------------------------------------------------------------------------------------------------
48 Contiguous
Persons in family or household states and DC Alaska Hawaii
----------------------------------------------------------------------------------------------------------------
1............................................................... $9,800 $12,250 $11,270
2............................................................... 13,200 16,500 15,180
3............................................................... 16,600 20,750 19,090
4............................................................... 20,000 25,000 23,000
5............................................................... 23,400 29,250 26,910
6............................................................... 26,800 33,500 30,820
7............................................................... 30,200 37,750 34,730
8............................................................... 33,600 42,000 38,640
For each additional person, add................................. 3,400 4,250 3,910
----------------------------------------------------------------------------------------------------------------
Source: 71 FR 3848 (Jan. 24, 2006).
[[Page 17566]]
Proposed Criteria for Donor Reimbursement
In addition to the eligibility and priority guidelines discussed
above, the following criteria for donor reimbursement are proposed:
1. Any individual who in good faith incurs qualifying expenses
toward the intended donation of an organ but with respect to whom, for
such reasons as the Secretary determines to be appropriate, no donation
of the organ occurs (see special provision). This criteria is
specifically discussed in the authorizing statute.
2. Donor and recipient of the organ are either U.S. citizens or
lawfully admitted residents of the U.S.
3. Donor and recipient have primary residence in the U.S. or its
territories.
4. Travel is originating from the donor's primary residence.
5. Donor meets the criteria for informed consent for the planned
procedure according to applicable State and Federal laws.
6. Donor and recipient are not participating in a paired exchange
program or a living donor/deceased donor exchange for the particular
donation procedure for which reimbursement is being sought unless the
legality of such practices is clarified by the Federal Government.
7. Donor and recipient attest to full compliance with section 301
of the National Organ Transplant Act (NOTA), as amended (42 U.S.C.
274e) which stipulates in part that `` * * * [i]t shall be unlawful for
any person to knowingly acquire, receive, or otherwise transfer any
human organ for valuable consideration for use in human transplantation
if the transfer affects interstate commerce.''
8. The transplant center where the donation procedure occurs
attests to its status of good standing with the Organ Procurement and
Transplantation Network (i.e., it is not a Member Not in Good Standing)
and assurance that the program follows best practices for the health
and safety of living donors such as the recommendations provided in the
Consensus Statement of the Ethics Committee of the Vancouver Forum on
living organ donation (Source: Pruett TL, Tibell A, Alabdulkareem A,
Bhandari M, Cronin DC, Dew MA, Dib-Kuri A, Gutmann T, Matas A, McMurdo
L, Rahmel A, Rizvi SA, Wright L, Delmonico FL. The ethics statement of
the Vancouver Forum on the live lung, liver, pancreas, and intestine
donor. Transplantation 81(10):1386-1387; (2006).
The public is invited to submit comments on these criteria.
Proposed Qualifying Expenses
For the purpose of the Reimbursement of Travel and Subsistence
Expenses toward Living Organ Donation Program, qualifying expenses
presently include only travel, lodging, and meals and incidental
expenses incurred by the donor and/or accompanying person(s) as part
of:
(1) Donor evaluation clinic visit or hospitalization;
(2) Hospitalization for the living donor surgical procedure; and/or
(3) Medical or surgical follow-up clinic visit or hospitalization
within 90 days after the living donation procedure.
The Program will pay for up to five trips per donation or intended
donation. Three of these trips may be for the potential living donor
and up to two trips may be for any accompanying person(s). The total
Federal reimbursement for qualified expenses during the donation
process for the donor and accompanying individuals shall not exceed
$6,000.
The public is invited to submit comments on these criteria.
Special Provisions
The authorizing statute provides that the Secretary may consider as
an eligible donating individual a person who in good faith incurs
qualifying expenses toward the intended donation of an organ but with
respect to whom, for reasons the Secretary determines to be
appropriate, no donation of the organ occurs. Many factors may prevent
the intended and willing donor from proceeding with the donation. Such
circumstances include present health status of the intended donor or
recipient that would prevent the transplant or donation from
proceeding, perceived long-term risks to the intended donor,
circumstances such as acts of God (e.g., major storms or hurricanes),
or other unforeseen events outside of the intended donor's control. In
such cases, the intended donor and accompanying persons may receive
reimbursement for the qualified expenses incurred. In the case that a
potential donor no longer wishes to donate, he or she may receive
reimbursement for qualified expenses incurred. However, payments
received for expenses that were not incurred by the intended donor and
accompanying persons must be refunded. Otherwise, such payment will be
treated as income to the intended donor, and in accordance with
Internal Revenue Service (IRS) regulations, the Regents of the
University of Michigan shall notify the IRS (Form 1099) that a payment
has been made to the intended donor in the amount equivalent to the
unexpended payment.
Dated: March 30, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7-6598 Filed 4-6-07; 8:45 am]
BILLING CODE 4165-15-P